Approved Class 1 innovative drugs (half year)
RecordSTO-KCA1ABEFQS-ZFJWEMVZ7Y-10SVF9
China · January–June 2026
Approved Class 1 innovative drugs in China (half year) were 38 in January–June 2026 (NHSA).
New drug approvals in China: every year, the rank and how it is measured
- Publisher
- NHSA
- Authority tier
- T1 Official
- Report
- 我国上半年创新药对外授权交易额超千亿美元
- Locator
- 今年38个1类创新药已获批上市 11款新靶点、新机制药均为国产
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
记者今天从国家药监局获悉，最新统计显示，今年上半年我国批准38个1类创新药上市。
Checked: the figure 38is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
National Healthcare Security Administration. (2026). 我国上半年创新药对外授权交易额超千亿美元. Retrieved September 17, 2026, from http://www.nhsa.gov.cn/art/2026/7/14/art_14_21423.html. Via StatOrigin, https://statorigin.org/stat/stat_KCA1ABEFQSZFJWEMVZ7Y10SVF9
Other formats: MLA, Chicago, BibTeX
- MLA
- National Healthcare Security Administration. "我国上半年创新药对外授权交易额超千亿美元." 2026, http://www.nhsa.gov.cn/art/2026/7/14/art_14_21423.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_KCA1ABEFQSZFJWEMVZ7Y10SVF9.
- Chicago
- National Healthcare Security Administration. "我国上半年创新药对外授权交易额超千亿美元." 2026. http://www.nhsa.gov.cn/art/2026/7/14/art_14_21423.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_KCA1ABEFQSZFJWEMVZ7Y10SVF9.
- BibTeX
- @misc{nhsa2026approved10svf9, author = {{National Healthcare Security Administration}}, title = {我国上半年创新药对外授权交易额超千亿美元}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_KCA1ABEFQSZFJWEMVZ7Y10SVF9}, note = {Original source: http://www.nhsa.gov.cn/art/2026/7/14/art\_14\_21423.html. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- National Healthcare Security Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- 我国上半年创新药对外授权交易额超千亿美元
- Type
- Press release
- Published
- —
- Locator
- 今年38个1类创新药已获批上市 11款新靶点、新机制药均为国产
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 26 September 2026
- Permanent URL
- /stat/stat_KCA1ABEFQSZFJWEMVZ7Y10SVF9